Research Topics
Species | J VolavkaSummaryAffiliation: Nathan Kline Institute Country: USA Publications
| Collaborators
|
Detail Information
Publications
Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studiesJan Volavka
The Nathan Kline Institute and New York University, 140 Old Orangeburg Road, Orangeburg, N Y 10962, USA
J Clin Psychiatry 66:1362-6. 2005..The objective was to determine the effects of aripiprazole on hostility...
COMT158 polymorphism and hostilityJan Volavka
Nathan Kline Institute, Orangeburg, New York 10982, USA
Am J Med Genet B Neuropsychiatr Genet 127:28-9. 2004..The Met-Met homozygotes (N = 7) were found to have significantly higher levels of hostility than the other patients (N = 53). The hypothesis was thus supported. The finding should be replicated in a larger sample...
Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidolJan Volavka
Nathan Kline Institute, Orangeburg, NY 10982, USA
J Clin Psychiatry 65:57-61. 2004....
Catecholamines and aggression: the role of COMT and MAO polymorphismsJan Volavka
Nathan Kline Institute, 140 Old Orangeburg Road, Orangeburg, New York 10962, USA
Ann N Y Acad Sci 1036:393-8. 2004..Collectively, these results suggest that COMT and MAOA polymorphisms represent a basic neurobiological mechanism that contributes to the regulation of aggressive behavior...
Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidolJan Volavka
Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10982, USA
J Clin Psychopharmacol 24:225-8. 2004..Clozapine appears to have superior antiaggresive effects in treatment-resistant patients; this superiority develops after the patient has been exposed to an adequate dose regimen...
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorderJan Volavka
Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10982, USA
Am J Psychiatry 159:255-62. 2002....
Atypical antipsychotics in the treatment of the persistently aggressive psychotic patient: methodological concernsJ Volavka
New York University, Department of Psychiatry, Nathan Kline Institue for Psychiatric Research, Orangeburg 10962, USA
Schizophr Res 35:S23-33. 1999..g. randomization) used in typical designs of psychopharmacological clinical trials. Current research methods should be modified and new ones developed in order to progress in assessing the antiaggressive effects of treatments...
The neurobiology of violence: an updateJ Volavka
Nathan Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
J Neuropsychiatry Clin Neurosci 11:307-14. 1999..Progress in the prevention and management of violent behavior depends on studies that address biological factors in their social context. This article updates a previous review...
Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophreniaL Citrome
Nathan Kline Institute for Psychiatric Research in Orangeburg, New York 10962, USA
Psychiatr Serv 52:1510-4. 2001..This study compared the specific antiaggressive effects of clozapine with those of olanzapine, risperidone, and haloperidol...
Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorderH M Lachman
Department of Psychiatry and Medicine, Albert Einstein College of Medicine, Orangeburg, N Y, USA
Am J Psychiatry 155:835-7. 1998..This study replicates and extends these findings by using more direct measures of violent behavior...
Suicidal behavior in patients with schizophrenia is related to COMT polymorphismK A Nolan
Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
Psychiatr Genet 10:117-24. 2000..These findings support a common neurobiological substrate for self- and other-directed aggression, and suggest that catecholaminergic alterations may contribute to these behaviors in schizophrenic and schizoaffective patients...
Heterogeneity of violence in schizophrenia and implications for long-term treatmentJ Volavka
Department of Psychiatry, New York University School of Medicine, New York, NY, USA
Int J Clin Pract 62:1237-45. 2008..The aim of this review is to address the subtyping of violent behaviour in schizophrenia, and to relate the subtypes to treatment...
Acute mania: haloperidol dose and augmentation with lithium or lorazepamJ C Chou
Nathan Kline Institute, Orangeburg, New York 10962, USA
J Clin Psychopharmacol 19:500-5. 1999..Lorazepam 4 mg/day was insufficient to produce an advantage when added to low-dose haloperidol...
An association between a polymorphism of the tryptophan hydroxylase gene and aggression in schizophrenia and schizoaffective disorderK A Nolan
Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
Psychiatr Genet 10:109-15. 2000..These results tend to support previous reports by New et al. (1996; 1998) of an association between the TPH L allele and impulsive aggression in males with personality disorder, but larger studies are needed...
Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorderJ C Chou
Nathan Kline Institute, Orangeburg, NY 10962, USA
Psychiatry Res 81:51-5. 1998..Further study of prolactin and clinical response to typical neuroleptics should focus on low neuroleptic doses...
Psychopathy and violent behavior among patients with schizophrenia or schizoaffective disorderK A Nolan
Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
Psychiatr Serv 50:787-92. 1999..Patients with and without a history of persistent violent behavior were compared for comorbidity of psychopathy and schizophrenia or schizoaffective disorder...
Haloperidol blood levels in acute mania with psychosisJ C Chou
Nathan Kline Institute, Orangeburg, New York 10962, USA
J Clin Psychopharmacol 21:445-7. 2001..Haloperidol blood levels may be clinically useful in identifying patients who are nonresponsive because of low drug levels and, hence, in enhancing optimal haloperidol dosing for acute mania with psychosis...
IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illnessB B Sheitman
Department of Psychiatry, University of North Carolina, Chapel Hill, NC, USA
Schizophr Res 46:203-7. 2000..807, P < 0.0001), while duration of illness (10-40 years) was unrelated to the magnitude of IQ score decline (r = -0.103, P = 0.575). These data suggest that pre-morbid IQ test scores are highly predictive of post-morbid scores...
Violent patients in the emergency settingL Citrome
Department of Psychiatry, New York University, New York, USA
Psychiatr Clin North Am 22:789-801. 1999..The use of typical neuroleptics may lead to side effects, such as akathisia, which may in turn precipitate additional agitation. This may be obviated with the introduction of IM preparations of atypical antipsychotics...
Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trialJ P Lindenmayer
Psychopharmacology Research Unit, Manhattan Psychiatric Unit, Manhattan Psychiatric Center, Wards Island, New York 10035, USA
J Clin Psychopharmacol 21:448-53. 2001..However, a trial with olanzapine can be recommended in these patients before moving to augmentation strategies, given the lack of proven alternatives and the observation that 16.7% of patients reached the response criteria...
Update on the biological treatment of aggressionJ Volavka
Nathan S. Kline Institute for Psychiatric Research, New York University, USA
Actas Esp Psiquiatr 34:123-35. 2006..The heterogeneity of aggressive behavior is a challenge for developing rational treatments. Emerging genetic findings hold a promise of future treatments of aggressive behavior developed on the basis of individual patients' genotypes...
Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study dataLeslie Citrome
Nathan S Kline Institute for Psychiatric Research and the New York University School of Medicine, Orangeburg, NY 10962, USA
J Clin Psychiatry 67:638-42. 2006..The objective was to determine the effects of sequential intramuscular/oral ziprasi-done on hostility...
Video recording in the assessment of violent incidents in psychiatric hospitalsKarea A Nolan
Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
J Psychiatr Pract 12:58-63. 2006..The ethical and responsible use of video surveillance of psychiatric inpatients has the potential to enhance our understanding and treatment of aggression...
Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorderMatthew J Hoptman
Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
Psychiatry Res 140:133-45. 2005..Larger left OFC gray matter volumes and larger OFC white matter volumes bilaterally were associated with greater levels of aggression. These findings are discussed in the context of potential iatrogenic effects...
Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO)Istvan Bitter
Department of Psychiatry and Psychotherapy, Semmelweis University, Balassa u 6, 1083 Budapest, Hungary
Eur Psychiatry 20:403-8. 2005..Antipsychotic medications may reduce hostile and aggressive behavior in schizophrenia. This study compared the effectiveness of antipsychotics in the treatment of aggression...
A cognitive, behaviorally based program for patients with persistent mental illness and a history of aggression, crime, or both: structure and correlates of completers of the programKathy Yates
New York University School of Medicine and Manhattan Psychiatric Center, Ward s Island Complex, NY 10035, USA
J Am Acad Psychiatry Law 33:214-22. 2005..In comparison with the 91 who did not complete the program, those who did were less cognitively impaired and less impulsive. We present a new, intensive treatment program and define the predictors of successful completion of the program...
Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophreniaDaniel J Muller
Neurogenetics Section, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada
Eur Neuropsychopharmacol 15:525-31. 2005..8 to 7%. Our results further suggest that this effect is only attributable to Caucasians when compared to African-Americans. Moreover, our findings point to the role of intracellular mechanisms in antipsychotic response...
Catechol-O-methyltransferase and monoamine oxidase-A polymorphisms and treatment response to typical and atypical neurolepticsKaren A Nolan
J Clin Psychopharmacol 26:338-40. 2006
Comparison of antipsychotic medication effects on reducing violence in people with schizophreniaJeffrey W Swanson
Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, 905 West Main Street, Durham, NC 27710, USA
Br J Psychiatry 193:37-43. 2008..Violence is an uncommon but significant problem associated with schizophrenia...
Are all antipsychotics equal?Jan Volavka
Lancet 372:201-2; author reply 202. 2008
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose studyBruce J Kinon
Eli Lilly and Company, Lilly Corporate Center, Drop Code 4133, Indianapolis, IN 46285, USA
J Clin Psychopharmacol 28:392-400. 2008....
Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trialsDonald C Goff
Massachusetts General Hospital, Harvard Medical School, 25 Staniford Street, Boston, MA 02114, USA
J Clin Psychopharmacol 27:582-9. 2007..We sought to evaluate the potential role of lamotrigine augmentation in schizophrenia patients resistant to atypical antipsychotic medication...
Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostilityLeslie Citrome
Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
Int Clin Psychopharmacol 22:356-62. 2007..In conclusion, although patients receiving combination treatment were more likely to complete the study, we were unable to detect a meaningful advantage for combination therapy as measured by rating scales...
HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysisVincenzo De Luca
Department of Psychiatry, Centre for Addiction and Mental Health, Neurogenetics Section, University of Toronto, Toronto, ON, Canada
Hum Psychopharmacol 22:463-7. 2007....
Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorderMatthew J Hoptman
Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
J Neuropsychiatry Clin Neurosci 18:509-15. 2006..The relationship between aggression and caudate volumes may be related to the iatrogenic effects of long-term treatment with typical antipsychotic agents or to a direct effect of schizophrenic processes on the caudate...
Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medicationGwyneth Zai
Neurogenetics Section, Centre for Addiction and Mental Health, Toronto, Canada
Psychopharmacology (Berl) 188:171-82. 2006..3, a region that has been found to be associated with SCZ in numerous linkage studies. One functional polymorphism, G-308A, has been studied for association with SCZ yielding inconsistent findings...
Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up studyJari Tiihonen
Department of Forensic Psychiatry, University of Kuopio, Niuvanniemi Hospital, FIN 70240 Kuopio, Finland
BMJ 333:224. 2006..To study the association between prescribed antipsychotic drugs and outcome in schizophrenia or schizoaffective disorder in the community...
Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluationJan Volavka
Schizophr Res 76:127-9. 2005
The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophreniaDaniel J Muller
Neurogenetics Section, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, 250 College Street R30, Toronto, Ont M5T 1R8, Canada
Neurosci Lett 379:81-9. 2005..Weight changes do not seem to be associated with polymorphism of the SNAP-25 gene, however, replication in independent samples is warranted...
Characteristics of assaultive behavior among psychiatric inpatientsKaren A Nolan
Nathan S Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, New York 10962, USA
Psychiatr Serv 54:1012-6. 2003..The purpose of this study was to assess the extent to which psychosis, disordered impulse control, and psychopathy contribute to assaults among psychiatric inpatients...
Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibilityKaren A Nolan
Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
Am J Psychiatry 161:359-61. 2004..They hypothesized that the Val and Met alleles would be associated with deficits in imitation learning and reversal learning, respectively...
Placebo or active control trials of antipsychotic drugs?W Wolfgang Fleischhacker
Department of Biological Psychiatry, Innsbruck University Clinics, Austria
Arch Gen Psychiatry 60:458-64. 2003..Sample size requirements for various equivalence margins in noninferiority trials are provided. Scientific and ethical arguments should lead to a more frequent use of the active-control noninferiority trial design...
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychoticsJean Pierre Lindenmayer
Nathan Kline Institute fo Psychiatric Research, New York, NY 10035, USA
Am J Psychiatry 160:290-6. 2003....
Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch studyJean Pierre Lindenmayer
Psychopharmacology Research Unit, Manhattan Psychiatric Center, Wards Island, NY 10035, USA
J Clin Psychiatry 63:931-5. 2002....
Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophreniaRobert M Bilder
Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
Biol Psychiatry 52:701-7. 2002....
Optimal dosing of atypical antipsychotics in adults: a review of the current evidenceLeslie Citrome
Department of Psychiatry, New York University, New York, N Y, USA
Harv Rev Psychiatry 10:280-91. 2002....
Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary studyMatthew J Hoptman
Division of Clinical Research and the Center for Advanced Brain Imaging, Nathan Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
Biol Psychiatry 52:9-14. 2002..CONCLUSIONS: Inferior frontal white matter microstructure was associated with impulsivity and aggression in men with schizophrenia. These results implicate frontal lobe dysfunction in aggression and certain aspects of impulsivity...
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorderRobert M Bilder
Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
Am J Psychiatry 159:1018-28. 2002....
Antipsychotic-induced weight gain and therapeutic response: a differential associationPal Czobor
Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
J Clin Psychopharmacol 22:244-51. 2002..These findings suggest that patients who are likely to have the maximal benefits of olanzapine or clozapine treatment for symptom alleviation are at the highest risk of a clinically significant increase in weight gain...
Olanzapine vs haloperidol for treatment of schizophreniaJan Volavka
JAMA 291:1064; author reply 1065-6. 2004
Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophreniaJean Pierre Lindenmayer
Nathan Kline Institute, Orangeburg, N Y, USA
J Clin Psychiatry 65:551-6. 2004..We are exploring whether this expanded clinical efficacy can also be seen in patients with treatment-resistant schizophrenia...
Identification of a naturally occurring 21 bp deletion in alpha 2c noradrenergic receptor gene and cognitive correlates to antipsychotic treatmentVincenzo De Luca
Neurogenetics Section, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, 250 College Street R 30, Toronto, Ont, Canada M5T 1R8
Pharmacol Res 51:381-4. 2005..Our results suggest that the novel polymorphism may not play a major role in antipsychotic response...
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioningLeslie Citrome
Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
Postgrad Med 116:49-51, 55-9, 63. 2004..In this article, the authors discuss the advantages and side effects of these agents and present a guide to help physicians choose the optimal drug in the most favorable formulation for each patient...
Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorderKaren A Nolan
Nathan Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA
J Psychiatr Res 39:109-15. 2005..These findings in chronic, treatment resistant inpatients support the view that positive symptoms may lead to aggression...
The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypesRobert M Bilder
Department of Psychiatry, David Geffen School of Medicine and Psychology, UCLA Neuropsychiatric Institute, University of California at Los Angeles, Los Angeles, CA, USA
Neuropsychopharmacology 29:1943-61. 2004....
Course of patients with histories of aggression and crime after discharge from a cognitive-behavioral programMichael Kunz
Huntington Department of Veterans Affairs Medical Center, West Virginia, USA
Psychiatr Serv 55:654-9. 2004..The predictors of poor outcome may be used to develop a follow-up treatment program that focuses more resources on patients who are at the highest risk...
Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statementLeslie Citrome
Diabetes Care 27:2087-8; author reply 2089-90. 2004
Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statementLeslie Citrome
J Clin Psychiatry 66:1073-4. 2005
Genetic linkage for schizophrenia?Jan Volavka
Am J Psychiatry 161:1134-5; author reply 1135-6. 2004
Screaming and physical aggression in nursing homesNunzio Pomara
Am J Geriatr Psychiatry 13:539-40. 2005
Risk for individuals with schizophrenia who are living in the communityJan Volavka
Psychiatr Serv 53:484-5; author reply 485. 2002
